Home Tags Seattle Genetics

Tag: Seattle Genetics

SGN-CD33A Demonstrates Encouraging Antitumor Activity in Acute Myeloid Leukemia

To-date, the treatment of acute myeloid leukemia or  AML remains general unsatisfactory.  Both the medical and scientific communities are looking for urgently needed novel...

Four-Year Survival Data from Brentuximab Vedotin Trial in Relapsed or Refractory...

Four-year overall survival (OS) data from the brentuximab vedotin (Adcetris®; Seattle Genetics) pivotal Phase II clinical trial in relapsed or refractory systemic anaplastic large cell...

SGN-CD19A Shows Encouraging Antitumor Activity in Recurrent Non-Hodgkin Lymphoma and...

Results from two ongoing phase I clinical trials evaluating SGN-CD19A (Seattle Genetics), an antibody-drug conjugate or ADC in development for the treatment of B-cell malignancies,...